Table 4: Study 2 results for c-Fos principal component analysis (PCA) factor scores after a high (Clinical) or low (Milk) dose of oral oxytocin (OXT) versus saline with whisker brushing in postnatal day (P) 14 and P21 male and female OXTR:EGFP mice.
Study 2 PCA c-Fos |
Mean ± SEM | p-value (ηp2) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Male | Female | Treat ment |
Sex | Age | T × S | T × A | A × S |
T × S × A |
post hoc | |||
P14 | P21 | P14 | P21 | |||||||||
Factor 1 sensory | ||||||||||||
Saline | 0.40 ± 0.52 | 0.47 ± 0.31 | 0.49 ± 0.25 | 0.25 ± 0.42 |
0.02 (0.09) |
0.94 (0.00) |
0.93 (0.00) |
0.96 (0.00) |
0.57 (0.02) |
0.04* (0.06) |
0.37 (0.03) |
saline > Clinical |
Milk | −0.27 ± 0.52 | 0.32 ± 0.35 | 0.64 ± 0.29 | −0.44 ± 0.14 | ||||||||
Clinical | −0.63 ± 0.37 | −0.02 ± 0.30 | −0.26 ± 0.38 | −0.31 ± 0.35 | ||||||||
Factor 2 PVN | ||||||||||||
Saline | −0.51 ± 0.24 | 0.37 ± 0.22 | −0.51 ± 0.34 | −0.60 ± 0.29 |
0.00 (0.18) |
0.00 (0.14) |
0.24 (0.02) |
0.00 (0.16) |
0.67 (0.01) |
0.00 (0.14) |
0.26 (0.04) |
♂saline < ♂Clinical ♂P14 < ♂P21 |
Milk | −0.54 ± 0.08 | −0.20 ± 0.37 | −0.12 ± 0.31 | −0.35 ± 0.32 | ||||||||
Clinical | 0.55 ± 0.43 | 1.63 ± 0.21 | 0.13 ± 0.29 | −0.68 ± 0.30 | ||||||||
Factor 3 motor | ||||||||||||
Saline | −0.39 ± 0.25 | 0.16 ± 0.30 | 1.22 ± 0.29 | 0.03 ± 0.43 | 0.23 (0.04) |
0.95 (0.00) |
0.71 (0.00) |
0.05 (0.08) |
0.41 (0.02) |
0.11 (0.03) |
0.16 (0.05) |
♀saline > ♀Milk & Clinical |
Milk | −0.04 ± 0.40 | 0.09 ± 0.44 | −0.59 ± 0.09 | −0.21 ± 0.31 | ||||||||
Clinical | −0.12 ± 0.47 | 0.44 ± 0.53 | −0.22 ± 0.19 | −0.18 ± 0.50 |